Emiko Noguchi

Emiko Noguchi

Auto-generated profile, based on publicly available information

Emiko Noguchi

Department of Medical Genetics, Institute of Medicine, University of Tsukuba, Ibaraki, Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2011 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
ENEmiko Noguchi
Emiko Noguchi
HSHiromi Sakamoto
Hiromi Sakamoto
THTomomitsu Hirota
Tomomitsu Hirota
KOKaori Ochiai
Kaori Ochiai
YIYoshimasa Imoto
Yoshimasa Imoto
KMKenji Matsumoto
Kenji Matsumoto
Asthma is a complex phenotype influenced by genetic and environmental factors. We conducted a genome-wide association study (GWAS) with 938 Japanese pediatric asthma patients and 2,376 controls. Single-nucleotide polymorphisms (SNPs) showing strong associations (P<1×10−8) in GWAS were further genotyped in an independent Japanese samples (818 cases and 1,032 controls) and in Korean samples (835 cases and 421 controls). SNP rs987870, located between HLA-DPA1 and HLA-DPB1, was consistently associated with pediatric asthma in 3 independent populations (Pcombined = 2.3×10−10, odds ratio [OR] = 1.40). HLA-DP allele analysis showed that DPA1*0201 and DPB1*0901, which were in strong linkage disequilibrium, were strongly associated with pediatric asthma (DPA1*0201: P = 5.5×10−10, OR = 1.52, and DPB1*0901: P = 2.0×10−7, OR = 1.49). Our findings show that genetic variants in the HLA-DP locus are associated with the risk of pediatric asthma in Asian populations. Asthma is the most common chronic disorder in children, and asthma exacerbation is an important cause of childhood morbidity and hospitalization. Here, taking advantage of recent technological advances in human genetics, we performed a genome-wide association study and follow-up validation studies to identify genetic variants for asthma. By examining 6,428 Asians, we found rs987870 and HLA-DPA1*0201/DPB1*0901 were associated with pediatric asthma. The association signal was stretched in the region of HLA-DPB2, collagen, type XI, alpha 2 (COL11A2), and Retinoid X receptor beta (RXRB), but strong linkage disequilibrium in this region made it difficult to specifically identify causative variants. Interestingly, the SNP (or the HLA-DP allele) associated with pediatric asthma (Th-2 type immune diseases) in the present study confers protection against Th-1 type immune diseases, such as type 1 diabetes and rheumatoid arthritis. Therefore, the association results obtained in the present study could partially explain the inverse relationship between asthma and Th-1 type immune diseases and may lead to better understanding of Th-1/Th-2 immune diseases.

1 October 2003 in Genes & Immunity
Verified
Journal Article
Open access
PDF file
YNY Nishio
Y Nishio
ENE Noguchi
E Noguchi
MSM Shibasaki
M Shibasaki
MKM Kamioka
M Kamioka
EIE Ichikawa
E Ichikawa
TAT Arinami
T Arinami
Atopy, which is characterized by increased levels of immunoglobulin E (IgE) against common environmental allergens, is considered the strongest predisposing factor for asthma and atopic dermatitis (AD). Mutations in the gene encoding serine protease inhibitor Kazal-type 5 (SPINK5) are responsible for Netherton syndrome, a rare skin disorder characterized by greatly elevated IgE levels with atopic manifestations. A recent study of Caucasian AD families showed that maternally derived alleles of the SPINK5 gene are associated with development of AD and asthma, suggesting the parent-of-origin effect for the development of atopic diseases in the SPINK5 gene. We studied the possible association of the SPINK5 gene for the development of atopic diseases by determining the genotypes of five polymorphisms in a Japanese population. Ttransmission disequilibrium tests revealed an association of SPINK5 polymorphisms with AD but not with asthma. Our data indicate that the SPINK5 gene is associated with AD across ethnicities.

30 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TNTakahiro Ninomiya
Takahiro Ninomiya
ENEmiko Noguchi
Emiko Noguchi
THTakenori Haruna
Takenori Haruna
MHMasayo Hasegawa
Masayo Hasegawa
TYTakuto Yoshida
Takuto Yoshida
SFShigeharu Fujieda
Shigeharu Fujieda
We previously reported that chronic rhinosinusitis with nasal polyps (CRSwNP) was subdivided into four chronic rhinosinusitis (CRS) subtypes using the JESREC scoring system. We sought to identify the gene expression profile and biomarkers related with CRSwNP by RNA-sequence. RNA-sequencing was performed to identify differentially expressed genes between nasal polyps (NPs) and inferior turbinate mucosa from 6 patients with CRSwNP, and subsequently, quantitative real-time PCR was performed to verify the results. ELISA was performed to identify possible biomarkers for postoperative recurrence. In the RNA-sequencing results, periostin (POSTN) expression was the highest in NP. We focused on POSTN and investigated the protein level of POSTN by immunohistochemistry and ELISA. POSTN was diffusely expressed in moderate and severe eosinophilic CRS using immunohistochemistry, and its staining pattern was associated with the severity of the phenotype of the CRSwNP (P < 0.05). There was a significant difference between the POSTN high/low groups for postoperative recurrence when the cutoff point was set at 115.5 ng/ml (P = 0.0072). Our data suggests that the protein expression level of POSTN was associated with the severity of CRSwNP, and serum POSTN can be a novel biomarker for postoperative recurrence of CRSwNP.

1 May 2016 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
YOYutaro Onizawa
Yutaro Onizawa
ENEmiko Noguchi
Emiko Noguchi
MOMasafumi Okada
Masafumi Okada
RSRyo Sumazaki
Ryo Sumazaki
DHDaisuke Hayashi
Daisuke Hayashi

15 July 2005 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ENEmiko Noguchi
Emiko Noguchi
YYYukako Yokouchi
Yukako Yokouchi
JZJiang Zhang
Jiang Zhang
KSKazuko Shibuya
Kazuko Shibuya
ASAkira Shibuya
Akira Shibuya
TATadao Arinami
Tadao Arinami
Rationale: Asthma is a common respiratory disease with complex genetic components. We previously reported strong evidence for linkage between mite-sensitive asthma and markers on chromosome 5q33. This area of linkage includes a region homologous to a mouse area that contains a locus involved in regulation of airway hyperreactivity. Objective: The aim of the present study is to identify asthma susceptibility genes on chromosome 5q33. Methods and Results: We performed mutation screening and association analyses of genes in the 9.4-Mb human linkage region. Transmission disequilibrium test analysis of 105 polymorphisms in 155 families with asthma revealed that six polymorphisms in cytoplasmic fragile X mental retardation protein (FMRP)–interacting protein 2 gene were associated significantly with the development of asthma (p = 0.000075; odds ratio, 5.9). These six polymorphisms were in complete linkage disequilibrium. In real-time quantitative polymerase chain reaction analysis, subjects homozygous for the haplotype overtransmitted to asthma-affected offspring showed significantly increased level of cytoplasmic FMRP interacting protein 2 gene expression in lymphocytes compared with ones heterozygous for the haplotype (p = 0.038). Conclusions: Our data suggest that cytoplasmic FMRP interacting protein 2 are associated with the development of atopic asthma in humans, and that targeting cytoplasmic FMRP interacting protein 2 could be a novel strategy for treating atopic asthma.

22 January 2009 in Clinical & Experimental Allergy
Verified
Journal Article
Open access
PDF file
TAT. Aoki
T. Aoki
YMY. Matsumoto
Y. Matsumoto
KHK. Hirata
K. Hirata
KOK. Ochiai
K. Ochiai
MOM. Okada
M. Okada
ENE. Noguchi
E. Noguchi
Summary: Background Asthma is a chronic airway inflammatory disease; however, the molecular mechanisms that underlie asthma exacerbation are only partially understood.Objective To identify gene expression signatures that reflect the acute exacerbation of asthma, we examined the differential expression of genes during asthma exacerbation and stable condition by using microarray analysis.Methods The subjects were mite‐sensitive asthmatic children and non‐asthmatic control children. The children were divided into four groups (AE: asthma exacerbation, n=12; SA: stable asthma, n=11; IC: infected control, n=6; and NC: non‐infected control, n=5). Total RNA was extracted from peripheral blood mononuclear cells and subjected to microarray analysis with Illumina Human Ref8 BeadChip arrays. Welch's t‐test was performed to identify genes whose expression was altered during asthma exacerbation. Quantitative real‐time RT‐PCR was performed on samples collected from 43 asthmatic children and 11 control children to verify the microarray results.Results The expression of 137/16 genes was significantly up/down‐regulated during asthma exacerbation assessed by microarray analysis. Of the genes, 62 were also differentially expressed during upper respiratory infection. Many of the asthma exacerbation related genes were involved in defence responses and responses to external stimuli, but these associations disappeared after excluding the infection‐related genes. Quantitative real‐time RT‐PCR confirmed that the genes related (S100A8 and GAS6) and unrelated to infections (CD200 and RBP7) were differentially expressed during asthma exacerbation (P<0.01).Conclusions Previously unidentified immune responses during asthma exacerbation may provide further clarification of the molecular mechanisms underlying asthma.